{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:57:32Z","timestamp":1759564652350,"version":"3.37.3"},"reference-count":263,"publisher":"National Institute for Health and Care Research","issue":"72","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["13\/17\/04"],"award-info":[{"award-number":["13\/17\/04"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Opioid substitution therapy and needle exchanges have reduced blood-borne viruses (BBVs) among people who inject drugs (PWID). Some PWID continue to share injecting equipment.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To develop an evidence-based psychosocial intervention to reduce BBV risk behaviours and increase transmission knowledge among PWID, and conduct a feasibility trial among PWID comparing the intervention with a control.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A pragmatic, two-armed randomised controlled, open feasibility trial. Service users were Steering Group members and co-developed the intervention. Peer educators co-delivered the intervention in London.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n NHS or third-sector drug treatment or needle exchanges in Glasgow, London, Wrexham and York, recruiting January and February 2016.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Current PWID, aged \u2265\u200918 years.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n A remote, web-based computer randomisation system allocated participants to a three-session, manualised, psychosocial, gender-specific group intervention delivered by trained facilitators and BBV transmission information booklet plus treatment as usual (TAU) (intervention), or information booklet plus TAU (control).<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Recruitment, retention and follow-up rates measured feasibility. Feedback questionnaires, focus groups with participants who attended at least one intervention session and facilitators assessed the intervention\u2019s acceptability.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A systematic review of what works to reduce BBV risk behaviours among PWID; in-depth interviews with PWID; and stakeholder and expert consultation informed the intervention. Sessions covered improving injecting technique and good vein care; planning for risky situations; and understanding BBV transmission. Fifty-six per cent (99\/176) of eligible PWID were randomised: 52 to the intervention group and 47 to the control group. Only 24% (8\/34) of male and 11% (2\/18) of female participants attended all three intervention sessions. Overall, 50% (17\/34) of men and 33% (6\/18) of women randomised to the intervention group and 47% (14\/30) of men and 53% (9\/17) of women randomised to the control group were followed up 1 month post intervention. Variations were reported by location. The intervention was acceptable to both participants and facilitators. At 1 month post intervention, no increase in injecting in \u2018risky\u2019 sites (e.g. groin, neck) was reported by participants who attended at least one session. PWID who attended at least one session showed a trend towards greater reduction in injecting risk behaviours, a greater increase in withdrawal planning and were more confident about finding a vein. A mean cost of \u00a358.17 per participant was calculated for those attending one session, \u00a3148.54 for those attending two sessions and \u00a3270.67 for those attending all three sessions, compared with \u00a30.86 in the control group. Treatment costs across the centres vary as a result of the different levels of attendance, as total session costs are divided by attendees to obtain a cost per attendee. The economic analysis suggests that a cost-effectiveness study would be feasible given the response rates and completeness of data. However, we have identified aspects where the service use questionnaire could be abbreviated given the low numbers reported in several care domains. No adverse events were reported.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n As only 19% of participants attended all three intervention sessions and 47% were followed up 1 month post intervention, a future definitive randomised controlled trial of the intervention is not feasible. Exposure to information on improving injecting techniques did not encourage riskier injecting practices or injecting frequency, and benefits were reported among attendees. The intervention has the potential to positively influence BBV prevention. Harm reduction services should ensure that the intervention content is routinely delivered to PWID to improve vein care and prevent BBVs.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n The intervention did not meet the complex needs of some PWID, more tailoring may be needed to reach PWID who are more frequent injectors, who are homeless and female.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Intervention delivery proved more feasible in London than other locations. Non-attendance at the York trial site substantially influenced the results.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN66453696 and PROSPERO 014:CRD42014012969.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 21, No. 72. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta21720","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T08:54:15Z","timestamp":1512550455000},"page":"1-312","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial"],"prefix":"10.3310","volume":"21","clinical-trial-number":[{"clinical-trial-number":"isrctn66453696","registry":"10.18810\/isrctn","type":"results"}],"author":[{"given":"Gail","family":"Gilchrist","sequence":"first","affiliation":[{"name":"National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davina","family":"Swan","sequence":"additional","affiliation":[{"name":"National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Shaw","sequence":"additional","affiliation":[{"name":"School of Media, Culture and Society, University of the West of Scotland, Paisley, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Keding","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Towers","sequence":"additional","affiliation":[{"name":"Betsi Cadwaladr University Health Board, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Craine","sequence":"additional","affiliation":[{"name":"Public Health Wales, Microbiology, Bangor, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Munro","sequence":"additional","affiliation":[{"name":"School of Media, Culture and Society, University of the West of Scotland, Paisley, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Applied Research in Health, School of Human and Health Sciences, University of Huddersfield, Huddersfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Parrott","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen","family":"Mdege","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[{"name":"School of Media, Culture and Society, University of the West of Scotland, Paisley, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of York, York, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2017,11]]},"reference":[{"volume-title":"The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and Injecting Risk Behaviours Among People Who Inject Drugs Attending Injecting Equipment Provision Services in Scotland, 2008\/2009 & 2010","year":"2012","author":"University of the West of Scotland, Health Protection Scotland, University of Strathclyde and the West of Scotland Specialist Virology Centre","key":"key20171201121137972_ref1-bib1"},{"volume-title":"Unlinked Anonymous Monitoring Survey of People Who Inject Drugs: Data Tables","year":"2015","author":"Public Health England, National Infection Service","key":"key20171201121137972_ref1-bib2"},{"key":"key20171201121137972_ref1-bib3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jvh.12117","article-title":"Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data","volume":"21","author":"Palmateer","year":"2014","journal-title":"J Viral Hepat"},{"key":"key20171201121137972_ref1-bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.23808","article-title":"Is sexual contact a major mode of hepatitis C virus transmission?","volume":"52","author":"Tohme","year":"2010","journal-title":"Hepatology"},{"key":"key20171201121137972_ref1-bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","article-title":"Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective","volume":"161","author":"Strathdee","year":"2001","journal-title":"Arch Intern Med"},{"key":"key20171201121137972_ref1-bib6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s10461-011-9991-1","article-title":"Psychiatric, behavioural and social risk factors for HIV infection among female drug users","volume":"15","author":"Gilchrist","year":"2011","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib7","first-page":"379","article-title":"A comparison of HIV risk between women and men who inject drugs","volume":"6","author":"Dwyer","year":"1994","journal-title":"AIDS Educ Prev"},{"key":"key20171201121137972_ref1-bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1037\/0893-164X.15.3.177","article-title":"Sex trading and psychological distress among women on methadone","volume":"15","author":"El-Bassel","year":"2001","journal-title":"Psychol Addict Behav"},{"key":"key20171201121137972_ref1-bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.qai.0000157006.28535.mL","article-title":"Requiring help injecting independently predicts incident HIV infection among injection drug users","volume":"40","author":"O\u2019Connell","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2013.05.014","article-title":"Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing","volume":"133","author":"Corson","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2893.2005.00643.x","article-title":"Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis","volume":"12","author":"Judd","year":"2005","journal-title":"J Viral Hepat"},{"key":"key20171201121137972_ref1-bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1024603517136","article-title":"Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity","volume":"18","author":"Backmund","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"key20171201121137972_ref1-bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.drugalcdep.2009.10.007","article-title":"Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting","volume":"107","author":"Bryant","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jech.2006.051599","article-title":"Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis","volume":"62","author":"Vescio","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"key20171201121137972_ref1-bib15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.addbeh.2008.07.005","article-title":"Injecting drug users\u2019 understanding of hepatitis C","volume":"33","author":"O\u2019Brien","year":"2008","journal-title":"Addict Behav"},{"key":"key20171201121137972_ref1-bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10826080902864894","article-title":"Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel","volume":"45","author":"Cohen-Moreno","year":"2010","journal-title":"Subst Use Misuse"},{"key":"key20171201121137972_ref1-bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2010.11.018","article-title":"Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs","volume":"116","author":"Treloar","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jsat.2005.11.005","article-title":"Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder","volume":"30","author":"Meade","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2215-0366(15)00357-0","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis","volume":"3","author":"Hughes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"key20171201121137972_ref1-bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2015.04.017","article-title":"Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England","volume":"152","author":"Gilchrist","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.nmd.0000230396.17230.28","article-title":"Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants","volume":"194","author":"Disney","year":"2006","journal-title":"J Nerv Ment Dis"},{"key":"key20171201121137972_ref1-bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1081\/ADA-200056793","article-title":"Reductions in HIV risk behaviors among depressed drug injectors","volume":"31","author":"Stein","year":"2005","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key20171201121137972_ref1-bib23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/09540121.2016.1173637","article-title":"Importance of substance use and violence in psychosocial syndemics among women with and at-risk for HIV","volume":"28","author":"Batchelder","year":"2016","journal-title":"AIDS Care"},{"key":"key20171201121137972_ref1-bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0899-3289(01)00065-7","article-title":"Abuse, addiction, and depression as pathways to sexual risk in women and men with a history of substance abuse","volume":"13","author":"Morrill","year":"2001","journal-title":"J Subst Abuse"},{"key":"key20171201121137972_ref1-bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00126334-200501010-00013","article-title":"The role of depressive symptoms in predicting sex with multiple and high-risk partners","volume":"38","author":"Williams","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2105\/AJPH.2003.023200","article-title":"Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone","volume":"95","author":"El-Bassel","year":"2005","journal-title":"Am J Public Health"},{"key":"key20171201121137972_ref1-bib27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dar.12436","article-title":"The prevalence and factors associated with ever perpetrating intimate partner violence by men receiving substance use treatment in Brazil and England: a cross-cultural comparison","volume":"36","author":"Gilchrist","year":"2017","journal-title":"Drug Alc Rev"},{"key":"key20171201121137972_ref1-bib28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10461-007-9309-5","article-title":"The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects","volume":"13","author":"Wagner","year":"2009","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10461-005-3899-6","article-title":"Intimate partner violence and monogamy among women in methadone treatment","volume":"9","author":"Hearn","year":"2005","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/09540120050123909","article-title":"Gendered power dynamics and HIV risk in drug-using sexual relationships","volume":"12","author":"MacRae","year":"2000","journal-title":"AIDS Care"},{"key":"key20171201121137972_ref1-bib31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0022042612466614","article-title":"From crime to recovery: the reframing of British drugs policy","volume":"43","author":"Duke","year":"2013","journal-title":"J Drug Issues"},{"volume-title":"The Road To Recovery: A New Approach to Tackling Scotland\u2019s Drug Problem","year":"2008","author":"The Scottish Government","key":"key20171201121137972_ref1-bib32"},{"volume-title":"Drug Strategy 2010 Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life","year":"2010","author":"HM Government","key":"key20171201121137972_ref1-bib33"},{"volume-title":"Putting Full Recovery First: The Recovery Roadmap","year":"2012","author":"UK Inter-Ministerial Group on Drugs","key":"key20171201121137972_ref1-bib34"},{"key":"key20171201121137972_ref1-bib35","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"key":"key20171201121137972_ref1-bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"key":"key20171201121137972_ref1-bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key20171201121137972_ref1-bib40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.drugalcdep.2016.05.012","article-title":"Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs","volume":"165","author":"Weir","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2015.06.032","article-title":"Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: implications for reinfection","volume":"154","author":"Valerio","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J Infect Dis"},{"key":"key20171201121137972_ref1-bib43","first-page":"CD007192","article-title":"Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users","volume":"1","author":"Meader","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key20171201121137972_ref1-bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugpo.2011.08.002","article-title":"Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review","volume":"23","author":"Sacks-Davis","year":"2012","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","article-title":"Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs","volume":"107","author":"Harris","year":"2012","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib46","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3109\/10826084.2012.682324","article-title":"Resilience among IDUs: planning strategies to help injection drug users to protect themselves and others from HIV\/HCV infections","volume":"47","author":"Sirikantraporn","year":"2012","journal-title":"Subst Use Misuse"},{"key":"key20171201121137972_ref1-bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1521\/aeap.2014.26.2.144","article-title":"The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection","volume":"26","author":"Mateu-Gelabert","year":"2014","journal-title":"AIDS Educ Prev"},{"key":"key20171201121137972_ref1-bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12954-015-0042-5","article-title":"A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: symbiotic messages, pleasure and conditional interpretations","volume":"12","author":"Treloar","year":"2015","journal-title":"Harm Reduct J"},{"key":"key20171201121137972_ref1-bib49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2458-8-94","article-title":"Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection","volume":"8","author":"Friedman","year":"2008","journal-title":"BMC Public Health"},{"key":"key20171201121137972_ref1-bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1049732311420579","article-title":"Staying safe from hepatitis C: engaging with multiple priorities","volume":"22","author":"Harris","year":"2012","journal-title":"Qual Health Res"},{"key":"key20171201121137972_ref1-bib51","doi-asserted-by":"crossref","first-page":"e77038","DOI":"10.1371\/journal.pone.0077038","article-title":"Hepatitis C avoidance in injection drug users: a typology of possible protective practices","volume":"8","author":"McGowan","year":"2013","journal-title":"PLOS ONE"},{"key":"key20171201121137972_ref1-bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/10826084.2015.1092991","article-title":"High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants \u2013 Is Prevention Failing?","volume":"51","author":"Folch","year":"2016","journal-title":"Subst Use Misuse"},{"key":"key20171201121137972_ref1-bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/003335491212700409","article-title":"Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles","volume":"127","author":"Gelberg","year":"2012","journal-title":"Public Health Rep"},{"volume-title":"Shooting Up: Infections Among People Who Inject Drugs in the United Kingdom 2012","year":"2013","author":"Public Health England","key":"key20171201121137972_ref1-bib54"},{"key":"key20171201121137972_ref1-bib55","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.19.30225","article-title":"Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection","volume":"21","author":"Hope","year":"2016","journal-title":"Euro Surveill"},{"key":"key20171201121137972_ref1-bib56","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s10461-012-0403-y","article-title":"An international systematic review and meta-analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs","volume":"17","author":"Meader","year":"2013","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2011.10.001","article-title":"Latent classes of heroin and cocaine users predict unique HIV\/HCV risk factors","volume":"122","author":"Harrell","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib58","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"key20171201121137972_ref1-bib59","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.drugalcdep.2007.08.010","article-title":"Baseline findings from the third collaborative injection drug users study\/drug users intervention trial (CIDUS III\/DUIT)","volume":"91","author":"Booth","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drugalcdep.2014.10.015","article-title":"Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012","volume":"145","author":"Jin","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.drugpo.2014.01.009","article-title":"WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs","volume":"25","author":"Walsh","year":"2014","journal-title":"Int J Drug Policy"},{"volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]","year":"2011","author":"Higgins","key":"key20171201121137972_ref1-bib62"},{"volume-title":"Systematic Reviews: CRD\u2019s Guidance For Undertaking Reviews in Health Care","year":"2008","author":"Centre for Reviews and Dissemination","key":"key20171201121137972_ref1-bib63"},{"key":"key20171201121137972_ref1-bib64","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"key20171201121137972_ref1-bib65","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"key20171201121137972_ref1-bib66","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key20171201121137972_ref1-bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"key20171201121137972_ref1-bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10461-010-9751-7","article-title":"Reducing HIV-related risk behaviors among injection drug users in residential detoxification","volume":"15","author":"Booth","year":"2011","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib69","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.socscimed.2008.11.019","article-title":"The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA","volume":"68","author":"Latkin","year":"2009","journal-title":"Soc Sci Med"},{"key":"key20171201121137972_ref1-bib70","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.2105\/AJPH.2007.126854","article-title":"Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviours among injection drug users","volume":"99","author":"Zule","year":"2009","journal-title":"Am J Public Health"},{"key":"key20171201121137972_ref1-bib71","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.addbeh.2005.07.009","article-title":"Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence","volume":"31","author":"Schroeder","year":"2006","journal-title":"Addict Behav"},{"key":"key20171201121137972_ref1-bib72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1037\/0278-6133.22.4.332","article-title":"HIV prevention among drug users: outcome of a network-oriented peer outreach intervention","volume":"22","author":"Latkin","year":"2003","journal-title":"Health Psychol"},{"key":"key20171201121137972_ref1-bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10852351003640914","article-title":"Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot intervention study","volume":"38","author":"Gilbert","year":"2010","journal-title":"J Prev Interv Community"},{"key":"key20171201121137972_ref1-bib74","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s10461-013-0563-4","article-title":"A peer-educator network HIV prevention intervention among injection drug users: results of a randomized controlled trial in St. Petersburg, Russia","volume":"17","author":"Hoffman","year":"2013","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-597X-7-1","article-title":"Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial","volume":"7","author":"Wechsberg","year":"2012","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"key20171201121137972_ref1-bib76","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1360-0443.2010.03146.x","article-title":"The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland","volume":"106","author":"Tobin","year":"2011","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib77","doi-asserted-by":"publisher","first-page":"e65812","DOI":"10.1371\/journal.pone.0065812","article-title":"Reductions in HIV\/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial","volume":"8","author":"Strathdee","year":"2013","journal-title":"PLOS ONE"},{"key":"key20171201121137972_ref1-bib78","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"key20171201121137972_ref1-bib79","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","article-title":"Statistics notes. The odds ratio","volume":"320","author":"Bland","year":"2000","journal-title":"BMJ"},{"key":"key20171201121137972_ref1-bib80","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key20171201121137972_ref1-bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1022565524508","article-title":"HIV risk reduction among African-American women who inject drugs: a randomized controlled trial","volume":"7","author":"Sterk","year":"2003","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib82","doi-asserted-by":"crossref","first-page":"e0125909","DOI":"10.1371\/journal.pone.0125909","article-title":"Efficacy of a multi-level intervention to reduce injecting and sexual risk behaviors among HIV-infected people who inject drugs in Vietnam: a four-arm randomized controlled trial","volume":"10","author":"Go","year":"2015","journal-title":"PLOS ONE"},{"key":"key20171201121137972_ref1-bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1037\/0893-164X.17.1.73","article-title":"Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up","volume":"17","author":"Epstein","year":"2003","journal-title":"Psychol Addict Behav"},{"key":"key20171201121137972_ref1-bib84","doi-asserted-by":"crossref","first-page":"286207","DOI":"10.1155\/2013\/286207","article-title":"Effectiveness of couple-based HIV counseling and testing for women substance users and their primary male partners: a randomized trial","volume":"2013","author":"McMahon","year":"2013","journal-title":"Adv Prev Med"},{"key":"key20171201121137972_ref1-bib85","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/1471-2458-12-653","article-title":"Mujer Mas Segura (safer women): a combination prevention intervention to reduce sexual and injection risks among female sex workers who inject drugs","volume":"12","author":"Vera","year":"2012","journal-title":"BMC Public Health"},{"key":"key20171201121137972_ref1-bib86","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/002204260203200316","article-title":"Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach","volume":"32","author":"Corsi","year":"2002","journal-title":"J Drug Issues"},{"key":"key20171201121137972_ref1-bib87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09595230220119327","article-title":"Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users","volume":"21","author":"Aitken","year":"2002","journal-title":"Drug Alcohol Rev"},{"key":"key20171201121137972_ref1-bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/030857590302700404","article-title":"Health problems in children adopted from Romania. Association with duration of deprivation and behavioural problems","volume":"27","author":"Beckett","year":"2003","journal-title":"Adopt Foster"},{"key":"key20171201121137972_ref1-bib89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(06)80009-8","article-title":"Predictors of risky needle use following interventions with injection drug users in Ukraine","volume":"82","author":"Booth","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib90","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1360-0443.2009.02660.x","article-title":"Interventions with injection drug users in Ukraine","volume":"104","author":"Booth","year":"2009","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib91","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.drugpo.2006.06.001","article-title":"Peer-driven HIV interventions for drug injectors in Russia: first year impact results of a field experiment","volume":"17","author":"Broadhead","year":"2006","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib92","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08897077.2011.540466","article-title":"Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users","volume":"32","author":"Copenhaver","year":"2011","journal-title":"Subst Abus"},{"key":"key20171201121137972_ref1-bib93","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City","volume":"21","author":"Des Jarlais","year":"2007","journal-title":"AIDS"},{"key":"key20171201121137972_ref1-bib94","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PSY.0b013e3181772157","article-title":"HIV prevention for injecting drug users: the first 25 years and counting","volume":"70","author":"Des Jarlais","year":"2008","journal-title":"Psychosom Med"},{"key":"key20171201121137972_ref1-bib95","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/09595230412331289437","article-title":"Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?","volume":"23","author":"Dolan","year":"2004","journal-title":"Drug Alcohol Rev"},{"key":"key20171201121137972_ref1-bib96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01.adt.0000137433.89024.64","article-title":"Increasing knowledge of HIV and hepatitis C during substance abuse treatment","volume":"4","author":"Evans","year":"2005","journal-title":"Addict Disord Their Treat"},{"key":"key20171201121137972_ref1-bib97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00132576-200403000-00003","article-title":"Hepatitis C knowledge assessment and counseling within the context of substance abuse treatment","volume":"3","author":"Evans","year":"2004","journal-title":"Addict Disord Their Treat"},{"key":"key20171201121137972_ref1-bib98","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874613601004030105","article-title":"Formative assessment of ARM-U: a modular intervention for decreasing risk behaviors among HIV-positive and HIV-negative methamphetamine-using MSM","volume":"4","author":"Garfein","year":"2010","journal-title":"Open AIDS J"},{"key":"key20171201121137972_ref1-bib99","doi-asserted-by":"crossref","first-page":"iv101","DOI":"10.1093\/jurban\/jti112","article-title":"Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection","volume":"82","author":"Gyarmathy","year":"2005","journal-title":"J Urban Health"},{"key":"key20171201121137972_ref1-bib100","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ajp.2013.06.001","article-title":"Mobile clinic services for opioid users: a feasible treatment modality","volume":"6","author":"Jhanjee","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"key20171201121137972_ref1-bib101","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1300\/J069v19n04_07","article-title":"Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment","volume":"19","author":"King","year":"2000","journal-title":"J Addict Dis"},{"key":"key20171201121137972_ref1-bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/00333549071220S108","article-title":"Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System","volume":"122","author":"Lansky","year":"2007","journal-title":"Public Health Rep"},{"key":"key20171201121137972_ref1-bib103","first-page":"1","article-title":"The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico","volume":"20","author":"Mayor","year":"2010","journal-title":"Ethn Dis"},{"key":"key20171201121137972_ref1-bib104","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1353\/hpu.2014.0015","article-title":"Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention","volume":"24","author":"Mayor","year":"2013","journal-title":"J Health Care Poor Underserved"},{"key":"key20171201121137972_ref1-bib105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/1471-2458-11-693","article-title":"Peer-based behavioral health program for drug users in China: a pilot study","volume":"11","author":"Shen","year":"2011","journal-title":"BMC Public Health"},{"key":"key20171201121137972_ref1-bib106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10464-009-9234-z","article-title":"Changing drug users\u2019 risk environments: peer health advocates as multi-level community change agents","volume":"43","author":"Weeks","year":"2009","journal-title":"Am J Community Psychol"},{"key":"key20171201121137972_ref1-bib107","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.drugpo.2005.08.003","article-title":"Evidence for action: a critical tool for guiding policies and programmes for HIV prevention, treatment and care among injecting drug users","volume":"16S","author":"Ball","year":"2005","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib108","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1360-0443.2006.01706.x","article-title":"The psychological science of addiction","volume":"102","author":"Gifford","year":"2007","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib109","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08897070109511466","article-title":"Methadone Anonymous: a 12-step program for methadone maintained heroin addicts","volume":"22","author":"Gilman","year":"2001","journal-title":"Subst Abus"},{"key":"key20171201121137972_ref1-bib110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00230-1","article-title":"Social relationships and intravenous drug use among methadone maintenance patients","volume":"64","author":"Gogineni","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0376-8716(00)00109-5","article-title":"Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study","volume":"60","author":"Gossop","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib112","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1360-0443.2000.95459110.x","article-title":"Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study","volume":"95","author":"Langendam","year":"2000","journal-title":"Addiction"},{"volume-title":"The SIC Project: Report (Safer Injecting CWIZ)","year":"2002","author":"Preston","key":"key20171201121137972_ref1-bib113"},{"key":"key20171201121137972_ref1-bib114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","article-title":"Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users","volume":"79","author":"Termorshuizen","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00002030-200206140-00011","article-title":"HIV prevalence and risk behaviour in young drug users in Amsterdam","volume":"16","author":"Welp","year":"2002","journal-title":"AIDS"},{"key":"key20171201121137972_ref1-bib116","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2105\/AJPH.90.7.1100","article-title":"HIV transmission and the cost-effectiveness of methadone maintenance","volume":"90","author":"Zaric","year":"2000","journal-title":"Am J Public Health"},{"volume-title":"Saving Lives by Reducing Harm: HIV Prevention and Treatment for Injecting Drug Users","year":"2006","author":"Open Society Institute, Public Health Programme","key":"key20171201121137972_ref1-bib117"},{"key":"key20171201121137972_ref1-bib118","doi-asserted-by":"publisher","first-page":"CD004145","DOI":"10.1002\/14651858.CD004145.pub3","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","volume":"2","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key20171201121137972_ref1-bib119","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.olq.0000135987.12346.f2","article-title":"Is HIV\/sexually transmitted disease prevention counseling effective among vulnerable populations?: a subset analysis of data collected for a randomized, controlled trial evaluating counseling efficacy (project RESPECT)","volume":"31","author":"Bolu","year":"2004","journal-title":"Sex Transm Dis"},{"key":"key20171201121137972_ref1-bib120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1521\/aeap.2005.17.4.317","article-title":"Developing an effective intervention for IDU women: a harm reduction approach to collaboration","volume":"17","author":"Brown","year":"2005","journal-title":"AIDS Educ Prev"},{"key":"key20171201121137972_ref1-bib121","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2005.07.005","article-title":"High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities","volume":"81","author":"Campbell","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.drugpo.2009.12.006","article-title":"Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales","volume":"21","author":"Costenbader","year":"2010","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib123","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14659890500520936","article-title":"Reducing the risk of exposure to HCV amongst injecting drug users: lessons from a peer intervention project in Northwest Wales","volume":"11","author":"Craine","year":"2006","journal-title":"J Subst Use"},{"key":"key20171201121137972_ref1-bib124","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/ADT.0b013e3180472098","article-title":"Developing an enhanced counseling intervention for the primary prevention of hepatitis C among injecting drug users","volume":"7","author":"Davis","year":"2008","journal-title":"Addict Disord Their Treat"},{"key":"key20171201121137972_ref1-bib125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2010.10.028","article-title":"Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention","volume":"55","author":"Drumright","year":"2011","journal-title":"J Hepatol"},{"key":"key20171201121137972_ref1-bib126","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/003335490612100611","article-title":"Self-reported hepatitis C virus antibody status and risk behavior in young injectors","volume":"121","author":"Hagan","year":"2006","journal-title":"Public Health Rep"},{"key":"key20171201121137972_ref1-bib127","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1360-0443.2008.02216.x","article-title":"Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients","volume":"103","author":"Hanson","year":"2008","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib128","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1360-0443.2011.03490.x","article-title":"Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China","volume":"106","author":"Hser","year":"2011","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib129","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/656776","article-title":"Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial","volume":"202","author":"Hwang","year":"2010","journal-title":"J Infect Dis"},{"volume-title":"The Effects of a Brief Cognitive-Behavioral Group Intervention on the Depression and Hopelessness of Drug Dependent, Human Immunodeficiency Virus-Positive, African-American Women","year":"2001","author":"Johnson","key":"key20171201121137972_ref1-bib130"},{"key":"key20171201121137972_ref1-bib131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QAI.0b013e318157892d","article-title":"What we can learn from the INSPIRE Study about improving prevention and clinical care for injection drug users living with HIV","volume":"46","author":"Jones","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib132","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1081\/ADA-200068114","article-title":"Social contextual factors associated with entry into opiate agonist treatment among injection drug users","volume":"31","author":"Lloyd","year":"2005","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key20171201121137972_ref1-bib133","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/09540120120057996","article-title":"Outcomes of a health education intervention in a sample of patients infected by HIV, most of them injection drug users: possibilities and limitations","volume":"13","author":"Martin","year":"2001","journal-title":"AIDS Care"},{"key":"key20171201121137972_ref1-bib134","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10461-014-0745-8","article-title":"Cost-effectiveness of interventions to prevent HIV and STDs among women: a randomized controlled trial","volume":"18","author":"Ruger","year":"2014","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib135","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1086\/427445","article-title":"Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users","volume":"40","author":"Strathdee","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key20171201121137972_ref1-bib136","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00124784-200511000-00006","article-title":"Economic evaluation of an HIV prevention intervention for seropositive injection drug users","volume":"11","author":"Tuli","year":"2005","journal-title":"J Public Health Manag Pract"},{"key":"key20171201121137972_ref1-bib137","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","article-title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial","volume":"384","author":"Weaver","year":"2014","journal-title":"Lancet"},{"key":"key20171201121137972_ref1-bib138","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0740-5472(03)00038-2","article-title":"Improving entry to methadone maintenance among out-of-treatment injection drug users","volume":"24","author":"Booth","year":"2003","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib139","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.drugalcdep.2003.12.009","article-title":"Factors associated with methadone maintenance treatment retention among street-recruited injection drug users","volume":"74","author":"Booth","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00952990601091093","article-title":"Treatment entry and predictors among opiate-using injection drug users","volume":"33","author":"Corsi","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key20171201121137972_ref1-bib141","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jurban\/jth114","article-title":"Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory","volume":"81","author":"Golub","year":"2004","journal-title":"J Urban Health"},{"key":"key20171201121137972_ref1-bib142","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0376-8716(01)00120-X","article-title":"Differences among out-of-treatment drug injectors who use stimulants only, opiates only or both: implications for treatment entry","volume":"64","author":"John","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib143","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.57.4.395","article-title":"Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance","volume":"57","author":"Preston","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"key20171201121137972_ref1-bib144","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1300\/J005v22n02_05","article-title":"Reduction of co-occurring distress and HIV risk behaviors among women substance abusers","volume":"22","author":"Reif","year":"2001","journal-title":"J Prev Interv Community"},{"key":"key20171201121137972_ref1-bib145","first-page":"103","volume":"17","author":"Program Targets HIV+ injection drug users","year":"2002","journal-title":"AIDS Alert"},{"key":"key20171201121137972_ref1-bib146","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2007.05.007","article-title":"Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study\/Drug Users Intervention Trial (CIDUS III\/DUIT)","volume":"91","author":"Garfein","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib147","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1553-2712.2012.01314.x","article-title":"Long-term follow-up after voluntary human immunodeficiency virus\/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency department","volume":"19","author":"Bernstein","year":"2012","journal-title":"Acad Emerg Med"},{"key":"key20171201121137972_ref1-bib148","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.drugalcdep.2013.08.007","article-title":"Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers","volume":"133","author":"Dunn","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib149","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/02791072.2003.10400490","article-title":"HIV\/AIDS among probationers: an assessment of risk and results from a brief intervention","volume":"35","author":"Martin","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"key20171201121137972_ref1-bib150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1521\/aeap.13.1.91.18921","article-title":"Effects of a cognitive-behavioral HIV prevention intervention among HIV negative male substance abusers in VA residential treatment","volume":"13","author":"McMahon","year":"2001","journal-title":"AIDS Educ Prev"},{"key":"key20171201121137972_ref1-bib151","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1080\/09540121.2013.793271","article-title":"Effects of a one-hour intervention on condom implementation intentions among drug users in Southern California","volume":"25","author":"Nydegger","year":"2013","journal-title":"AIDS Care"},{"key":"key20171201121137972_ref1-bib152","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s10461-013-0557-2","article-title":"Results of a pilot test of a brief computer-assisted tailored HIV prevention intervention for use with a range of demographic and risk groups","volume":"17","author":"Zule","year":"2013","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib153","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s10461-013-0539-4","article-title":"A randomized controlled trial of the Community-friendly Health Recovery Program (CHRP) among high-risk drug users in treatment","volume":"17","author":"Copenhaver","year":"2013","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib154","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.addbeh.2007.11.009","article-title":"Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients","volume":"33","author":"Ghitza","year":"2008","journal-title":"Addict Behav"},{"key":"key20171201121137972_ref1-bib155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"key":"key20171201121137972_ref1-bib156","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1176\/appi.ajp.2013.13070987","article-title":"Computer-assisted delivery of cognitive-behavioural therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone","volume":"171","author":"Carroll","year":"2014","journal-title":"Am J Psychiatry"},{"key":"key20171201121137972_ref1-bib157","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1477-7517-6-36","article-title":"Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users","volume":"6","author":"Grau","year":"2009","journal-title":"Harm Reduct J"},{"key":"key20171201121137972_ref1-bib158","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2190\/1DWM-D9WA-22R1-70Q0","article-title":"Reducing HIV\/AIDS high-risk behavior among injection drug users: peers vs. education","volume":"30","author":"Madray","year":"2000","journal-title":"J Drug Educ"},{"key":"key20171201121137972_ref1-bib159","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5993\/AJHB.28.4.3","article-title":"Efficacy of computer-based HIV\/AIDS education for injection drug users","volume":"28","author":"Marsch","year":"2004","journal-title":"Am J Health Behav"},{"key":"key20171201121137972_ref1-bib160","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1360-0443.2000.951116314.x","article-title":"Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome","volume":"95","author":"Strang","year":"2000","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib161","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10461-012-0134-0","article-title":"The impact of a brief motivational intervention on unprotected sex and sex while high among drug-positive emergency department patients who receive STI\/HIV VC\/T and drug treatment referral as standard of care","volume":"16","author":"Bernstein","year":"2012","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib162","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drugalcdep.2009.07.015","article-title":"Brief counseling for reducing sexual risk and bacterial STIs among drug users \u2013 results from project RESPECT","volume":"106","author":"Semaan","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0091-7435(03)00090-2","article-title":"Who\u2019s getting the message? Intervention response rates among women who inject drugs and\/or smoke crack cocaine","volume":"37","author":"Sterk","year":"2003","journal-title":"Prev Med"},{"key":"key20171201121137972_ref1-bib164","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/QAI.0b013e3181a265b2","article-title":"Predictors of sexual risk reduction among Mexican female sex workers enrolled in a behavioral intervention study","volume":"51","author":"Strathdee","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib165","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1009555304568","article-title":"An evaluation of a brief HIV risk reduction intervention using empirically derived drug use and sexual risk indices","volume":"5","author":"Williams","year":"2001","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib166","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jsat.2008.11.004","article-title":"The effect of methadone maintenance on positive outcomes for opiate injection drug users","volume":"37","author":"Corsi","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib167","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1360-0443.2006.01431.x","article-title":"The dynamics of injection drug users\u2019 personal networks and HIV risk behaviors","volume":"101","author":"Costenbader","year":"2006","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib168","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00126334-200401010-00012","article-title":"Predictors of self-reported HIV infection among drug injectors in Ukraine","volume":"35","author":"Booth","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib169","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/jurban\/jth112","article-title":"Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities","volume":"81","author":"Garfein","year":"2004","journal-title":"J Urban Health"},{"key":"key20171201121137972_ref1-bib170","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib171","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00042560-200104150-00014","article-title":"Methadone maintenance as HIV risk reduction with street-recruited injecting drug users","volume":"26","author":"Kwiatkowski","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib172","first-page":"112","article-title":"Peer education on harm reduction in intravenous drug users in Kunming","volume":"2","author":"Jian","year":"2002","journal-title":"Chin Ment Health J"},{"key":"key20171201121137972_ref1-bib173","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7517-5-25","article-title":"The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned","volume":"5","author":"Abou-Saleh","year":"2008","journal-title":"Harm Reduct J"},{"key":"key20171201121137972_ref1-bib174","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(03)00159-4","article-title":"Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy","volume":"26","author":"Avants","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib175","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/add.12867","article-title":"Randomized controlled trial of motivational interviewing for reducing injection risk behaviours among people who inject drugs","volume":"110","author":"Bertrand","year":"2015","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib176","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1081\/ADA-100104515","article-title":"Lowering HIV risk among ethnic minority drug users: comparing culturally targeted intervention to a standard intervention","volume":"27","author":"Dushay","year":"2001","journal-title":"Am J Drug Alcohol Abuse"},{"key":"key20171201121137972_ref1-bib177","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/QAI.0b013e318229eab1","article-title":"Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks","volume":"58","author":"El-Bassel","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib178","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10461-009-9651-x","article-title":"A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users","volume":"14","author":"Gagnon","year":"2010","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib179","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","article-title":"A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users","volume":"21","author":"Garfein","year":"2007","journal-title":"AIDS"},{"key":"key20171201121137972_ref1-bib180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.socscimed.2013.07.006","article-title":"Effects of an HIV peer prevention intervention on sexual and injecting risk behaviors among injecting drug users and their risk partners in Thai Nguyen, Vietnam: a randomized controlled trial","volume":"96","author":"Go","year":"2013","journal-title":"Soc Sci Med"},{"key":"key20171201121137972_ref1-bib181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1025487501743","article-title":"A cognitive\u2013behavioral intervention to reduce HIV risk behaviors in crack and injection drug users","volume":"7","author":"Hershberger","year":"2003","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib182","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2105\/AJPH.2007.113415","article-title":"A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C","volume":"98","author":"Latka","year":"2008","journal-title":"Am J Public Health"},{"key":"key20171201121137972_ref1-bib183","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s10461-012-0373-0","article-title":"Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3\/DUIT study","volume":"17","author":"Mackesy-Amiti","year":"2013","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib184","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s10461-013-0601-2","article-title":"Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention","volume":"18","author":"Mackesy-Amiti","year":"2014","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib185","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1360-0443.2010.03251.x","article-title":"Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial","volume":"106","author":"Mackesy-Amiti","year":"2011","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib186","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1037\/0278-6133.22.2.223","article-title":"A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users","volume":"22","author":"Margolin","year":"2003","journal-title":"Health Psychol"},{"key":"key20171201121137972_ref1-bib187","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11121-014-0540-9","article-title":"Couple-based HIV counseling and testing: a risk reduction intervention for US drug-involved women and their primary male partners","volume":"16","author":"McMahon","year":"2015","journal-title":"Prev Sci"},{"key":"key20171201121137972_ref1-bib188","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2011.06.012","article-title":"Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care","volume":"120","author":"Otiashvili","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib189","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1097\/01.qai.0000140609.44016.c4","article-title":"Interventions for seropositive injectors \u2013 research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction","volume":"37","author":"Purcell","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib190","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/QAI.0b013e31815767c4","article-title":"Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users","volume":"46","author":"Purcell","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20171201121137972_ref1-bib191","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.drugalcdep.2007.03.004","article-title":"Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users","volume":"91","author":"Purcell","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib192","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsat.2004.06.004","article-title":"Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study","volume":"27","author":"Robles","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib193","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10461-009-9606-2","article-title":"Reducing HIV risks among active injection drug and crack users: the safety counts program","volume":"14","author":"Rotheram-Borus","year":"2010","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib194","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/add.12716","article-title":"HERMITAGE \u2013 a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers","volume":"110","author":"Samet","year":"2015","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0740-5472(01)00207-0","article-title":"A brief intervention for hazardous drinkers in a needle exchange program","volume":"22","author":"Stein","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"key20171201121137972_ref1-bib196","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10550880903183034","article-title":"A trial to reduce hepatitis C seroincidence in drug users","volume":"28","author":"Stein","year":"2009","journal-title":"J Addict Dis"},{"key":"key20171201121137972_ref1-bib197","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1360-0443.2004.00809.x","article-title":"Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users","volume":"99","author":"Tucker","year":"2004","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib198","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11524-006-9133-7","article-title":"Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE)","volume":"81","author":"Kapadia","year":"2007","journal-title":"J Urban Health"},{"key":"key20171201121137972_ref1-bib199","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/add.12095","article-title":"The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users","volume":"108","author":"Latkin","year":"2013","journal-title":"Addiction"},{"key":"key20171201121137972_ref1-bib200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsat.2006.04.002","article-title":"Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy","volume":"31","author":"Copenhaver","year":"2006","journal-title":"J Subst Abuse Treat"},{"volume-title":"REDUCE: Reducing Hepatitis C Risk Behaviours Among Female Drug Users in Europe","key":"key20171201121137972_ref1-bib201"},{"volume-title":"Training Guide for HIV Prevention Outreach to Injecting Drug Users","author":"World Health Organization","key":"key20171201121137972_ref1-bib202"},{"volume-title":"The NIDA Community-Based Outreach Model: A Manual to Reduce the Risk of HIV and Other Blood-Borne infections in Drug Users","author":"National Institute on Drug Abuse","key":"key20171201121137972_ref1-bib203"},{"volume-title":"UFO Model Replication Manual: A Hep C Intervention for Young Adult IDU","author":"Implementing UFO: HCV Education and Support Group","key":"key20171201121137972_ref1-bib204"},{"volume-title":"REMAS: A Gender-Focused HIV & Sexual Risk Reduction Intervention for Men in Substance Abuse Treatment","author":"Calsyn","key":"key20171201121137972_ref1-bib205"},{"volume-title":"Safety Counts Program Manual: A Cognitive\u2013Behavioural Intervention to Reduce HIV\/Hepatitis Risks Among Drug Users Who Are Not in Drug Treatment","author":"AED: Center on AIDS & Community Health","key":"key20171201121137972_ref1-bib206"},{"volume-title":"Staying Safe: A Sociology of How People Who Inject Drugs Avoid Hepatitis C in the Long Term","author":"Economic and Social Research Council","key":"key20171201121137972_ref1-bib207"},{"journal-title":"The Hepatitis C Treatment Journey: A Prospective Qualitative Longitudinal Study Addressing Patient, Provider and System Perspectives","author":"Harris","key":"key20171201121137972_ref1-bib208"},{"volume-title":"HCV Treatment: Barriers and Facilitators to Hepatitis C Treatment For People Who Inject Drugs","author":"World Health Organization","key":"key20171201121137972_ref1-bib209"},{"key":"key20171201121137972_ref1-bib210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","article-title":"Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors","volume":"10","author":"Harris","year":"2013","journal-title":"Harm Reduct J"},{"key":"key20171201121137972_ref1-bib211","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.drugalcdep.2013.04.012","article-title":"Injecting practices in sexual partnerships: hepatitis C transmission potentials in a \u2018risk equivalence\u2019 framework","volume":"132","author":"Harris","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"key20171201121137972_ref1-bib212","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/09687637.2014.899988","article-title":"Hepatitis C testing for people who inject drugs in the United Kingdom: why is uptake so low?","volume":"21","author":"Harris","year":"2014","journal-title":"Drugs Educ Prev Policy"},{"key":"key20171201121137972_ref1-bib213","doi-asserted-by":"crossref","first-page":"19e26","DOI":"10.1016\/j.socscimed.2013.01.031","article-title":"Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting","volume":"83","author":"Harris","year":"2013","journal-title":"Soc Sci Med"},{"volume-title":"Common Sense Ideas for HIV Prevention and Sexual Health","year":"2005","author":"Bartholomew","key":"key20171201121137972_ref1-bib214"},{"volume-title":"Routes To Recovery 1, 2, 4, 5, 6","author":"Public Health England","key":"key20171201121137972_ref1-bib215"},{"volume-title":"Routes to Recovery Via the Community: Mapping User Manual","author":"Public Health England","key":"key20171201121137972_ref1-bib216"},{"volume-title":"Routes to Recovery Psychosocial Interventions for Drug Misuse. A Framework and Toolkit For Implementing NICE-Recommended Treatment","author":"The British Psychological Society","key":"key20171201121137972_ref1-bib217"},{"volume-title":"Straight Ahead: Transition Skills for Recovery","year":"1993","author":"Bartholomew","key":"key20171201121137972_ref1-bib218"},{"volume-title":"Tools For Change","author":"South Eastern Health and Social Care Trust","key":"key20171201121137972_ref1-bib219"},{"volume-title":"The Bouncing Back Workbook: Building Skills That Strengthen Resilience","author":"South Eastern Health and Social Care Trust","key":"key20171201121137972_ref1-bib220"},{"volume-title":"The Resilience Factor: 7 Keys to Finding Your Inner Strength and Overcoming Life\u2019s Hurdles","year":"2002","author":"Reivich","key":"key20171201121137972_ref1-bib221"},{"journal-title":"Drug and Alcohol Recovery and Treatment Tool (DARTT)","author":"Blenheim","key":"key20171201121137972_ref1-bib222"},{"key":"key20171201121137972_ref1-bib223","first-page":"173","volume-title":"Analysing Qualitative Data","author":"Richie","year":"1993"},{"key":"key20171201121137972_ref1-bib224","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"key20171201121137972_ref1-bib225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1207\/s15430421tip3903_2","article-title":"Determining validity in qualitative inquiry","volume":"39","author":"Creswell","year":"2000","journal-title":"Theory Into Practice"},{"volume-title":"UK Medical Research Council (MRC) Guidance. Process Evaluation of Complex Interventions","year":"2014","author":"Moore","key":"key20171201121137972_ref1-bib226"},{"key":"key20171201121137972_ref1-bib227","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/cbm.34","article-title":"The manualization of a treatment programme for personality disorder","volume":"15","author":"McMurran","year":"2005","journal-title":"Crim Behav Ment Health"},{"key":"key20171201121137972_ref1-bib228","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2006.08.028","article-title":"Training and fidelity monitoring of behavioral interventions in multi-site addictions research","volume":"87","author":"Baer","year":"2007","journal-title":"Drug Alcohol Depend"},{"volume-title":"Exchange Supplies","key":"key20171201121137972_ref1-bib229"},{"volume-title":"Australian Injecting & Illicit Drug Users League","key":"key20171201121137972_ref1-bib230"},{"volume-title":"Hep C Info. Understanding Hepatitis C and Staying Safe","author":"Booklet 1","key":"key20171201121137972_ref1-bib231"},{"volume-title":"Reducing the Harm Associated With Injecting Drug Use","author":"Safer Injecting . . .","key":"key20171201121137972_ref1-bib232"},{"volume-title":"Tips for Vein Care","author":"Drugs and Health Development Project","key":"key20171201121137972_ref1-bib233"},{"key":"key20171201121137972_ref1-bib234","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","article-title":"Design and analysis of pilot studies: recommendations for good practice","volume":"10","author":"Lancaster","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"key20171201121137972_ref1-bib235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm Stat"},{"key":"key20171201121137972_ref1-bib236","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2288-10-67","article-title":"What is a pilot or feasibility study? A review of current practice and editorial policy","volume":"10","author":"Arain","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"key20171201121137972_ref1-bib237","article-title":"An uncontrolled, feasibility study of a group intervention to reduce hepatitis C transmission risk behaviors and increase transmission knowledge among women who inject drugs","author":"Gilchrist","year":"2016","journal-title":"Drugs Educ Prev Policy"},{"key":"key20171201121137972_ref1-bib238","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s10461-011-0079-8","article-title":"Correlates of staying safe behaviors among long-term injection drug users: psychometric evaluation of the staying safe questionnaire","volume":"16","author":"Vazan","year":"2012","journal-title":"AIDS Behav"},{"key":"key20171201121137972_ref1-bib239","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1521\/aeap.14.2.172.23902","article-title":"Development and psychometric evaluation of the brief HIV Knowledge Questionnaire","volume":"14","author":"Carey","year":"2002","journal-title":"AIDS Educ Prev"},{"key":"key20171201121137972_ref1-bib240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1471-6712.2008.00668.x","article-title":"Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale","volume":"23","author":"Balfour","year":"2009","journal-title":"Scand J Caring Sci"},{"key":"key20171201121137972_ref1-bib241","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/1753-6405.12378","article-title":"Hepatitis B knowledge and associated factors among people with chronic hepatitis B","volume":"39","author":"Hajarizadeh","year":"2015","journal-title":"Aust N Z J Public Health"},{"key":"key20171201121137972_ref1-bib242","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"volume-title":"Drug Misuse: Psychosocial Interventions. NICE Clinical Guideline 51","year":"2007","author":"National Institute for Health and Care Excellence","key":"key20171201121137972_ref1-bib243"},{"key":"key20171201121137972_ref1-bib244","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLOS Med"},{"key":"key20171201121137972_ref1-bib245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","article-title":"Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report","volume":"18","author":"Ramsey","year":"2015","journal-title":"Value Health"},{"key":"key20171201121137972_ref1-bib246","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"volume-title":"Unit Costs of Health and Social Care 2014","year":"2014","author":"Curtis","key":"key20171201121137972_ref1-bib247"},{"volume-title":"NHS Reference Costs 2013\/14","year":"2014","author":"Department of Health","key":"key20171201121137972_ref1-bib248"},{"volume-title":"Unit Costs of Health and Social Care 2008","year":"2008","author":"Curtis","key":"key20171201121137972_ref1-bib249"},{"volume-title":"Prescription Cost Analysis England 2013","year":"2014","author":"NHS Digital","key":"key20171201121137972_ref1-bib250"},{"volume-title":"Unit Costs of Health and Social Care 2009","year":"2009","author":"Curtis","key":"key20171201121137972_ref1-bib251"},{"volume-title":"Flows and Costs in the Criminal Process","year":"1997","author":"Field","key":"key20171201121137972_ref1-bib252"},{"volume-title":"Public Expenditure Statistical Analyses 2013","year":"2013","author":"HM Treasury","key":"key20171201121137972_ref1-bib253"},{"volume-title":"Costs per Place and Costs per Prisoner. National Offender Management Service Annual Report and Accounts 2013-14 Management Information Addendum. Ministry of Justice Information Release","year":"2014","author":"Ministry of Justice","key":"key20171201121137972_ref1-bib254"},{"volume-title":"At the Sharp End. A Snapshot of 21st Century Injecting Drug Use","author":"Turning Point","key":"key20171201121137972_ref1-bib255"},{"key":"key20171201121137972_ref1-bib256","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/medethics-2012-100884","article-title":"Relative efficacy of cash versus vouchers in engaging opioid substitution treatment clients in survey-based research","volume":"39","author":"Topp","year":"2013","journal-title":"J Med Ethics"},{"key":"key20171201121137972_ref1-bib257","doi-asserted-by":"crossref","DOI":"10.1080\/14659891.2016.1259367","article-title":"Paying participants in addiction research: is cash king? [published online ahead of print 25 January 2007]","author":"Neale","year":"2017","journal-title":"J Subst Use"},{"volume-title":"Quality Standard for Drug Use Disorders","year":"2012","author":"National Institute for Health and Care Excellence","key":"key20171201121137972_ref1-bib258"},{"key":"key20171201121137972_ref1-bib259","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.drugpo.2015.07.013","article-title":"\u2018Chemsex\u2019 and harm reduction need among gay men in South London","volume":"26","author":"Bourne","year":"2015","journal-title":"Int J Drug Policy"},{"key":"key20171201121137972_ref1-bib260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(13)61609-8","article-title":"New HIV diagnoses in London\u2019s gay men continue to soar","volume":"382","author":"Kirby","year":"2013","journal-title":"Lancet"},{"key":"key20171201121137972_ref1-bib261","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7861\/clinmedicine.16-2-189","article-title":"Hepatitis C and sex","volume":"16","author":"Page","year":"2016","journal-title":"Clin Med"},{"key":"key20171201121137972_ref1-bib262","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0956462416651229","article-title":"Chemsex and the city: sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics","volume":"28","author":"Hegazi","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key20171201121137972_ref1-bib263","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/sextrans-2015-052052","article-title":"Illicit drug use in sexual settings (\u2018chemsex\u2019) and HIV\/STI transmission risk behaviour among gay men in South London: findings from a qualitative study","volume":"91","author":"Bourne","year":"2015","journal-title":"Sex Transm Infect"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta21720\/hta21720.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta21720\/hta21720.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2011710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:40:58Z","timestamp":1692114058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta21720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":263,"journal-issue":{"issue":"72","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["10.3310\/hta21720"],"URL":"https:\/\/doi.org\/10.3310\/hta21720","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"type":"print","value":"1366-5278"},{"type":"electronic","value":"2046-4924"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}